Semaglutide improves maximal walking distance in people with symptomatic PAD and Type 2 diabetes

Semaglutide, a glucagon-like peptide 1 (GLP-1) agonist, significantly improved maximal walking distance in people with symptomatic peripheral artery disease (PAD) and Type 2 diabetes in the first-of-its kind trial to…

Continue ReadingSemaglutide improves maximal walking distance in people with symptomatic PAD and Type 2 diabetes

Bentracimab reverses ticagrelor’s antiplatelet effects during surgery and bleeding events

A drug developed as an antidote to the antiplatelet agent ticagrelor safely and effectively reversed ticagrelor's antiplatelet effects in patients undergoing urgent surgery or experiencing major bleeding, according to a…

Continue ReadingBentracimab reverses ticagrelor’s antiplatelet effects during surgery and bleeding events

Study finds 4F-PCC superior to frozen plasma in reducing bleeding after cardiac surgery

In patients experiencing excessive bleeding during cardiac surgery, a concentrated blood product containing proteins that help the blood clot was significantly more effective and caused fewer adverse effects than frozen…

Continue ReadingStudy finds 4F-PCC superior to frozen plasma in reducing bleeding after cardiac surgery